Change - Announcement of Cessation::Retirement of Director

Issuer & Securities

Issuer/ Manager
ASIAMEDIC LIMITED
Securities
ASIAMEDIC LIMITED - SG0505000059 - 505
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
08-Apr-2026 18:05:39
Status
New
Announcement Sub Title
Retirement of Director
Announcement Reference
SG260408OTHRB90G
Submitted By (Co./ Ind. Name)
Syenny Yu
Designation
CFO
Description (Please provide a detailed description of the event in the box below)
Retirement of Director

This announcement has been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd ("Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Pauline Sim, Head of Corporate Finance, at 3 Shenton Way, #24-02 Shenton House, Singapore 068805, telephone (65) 6319 4954.

Additional Details

Name of person
Leong Yew Meng
Age
66
Is effective date of cessation known?
Yes
If yes, please provide the date.
29/04/2026
Detailed reason(s) for cessation
Mr Leong Yew Meng will retire at the conclusion of the forthcoming annual general meeting to be held on 29 April 2026 pursuant to Regulation 89 of the Company's Constitution, and does not seek re-election. Mr Leong wishes to devote more time to his personal pursuits. He will concurrently relinquish his positions as Chairman of the Remuneration Committee and member of the Nominating Committee.

The Company's Sponsor, Xandar Capital Pte Ltd, has interviewed Mr Leong and is satisfied that, other than the reason as disclosed above, there are no material reasons for his retirement.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
Yes
If yes, please elaborate.
The Board is in the process of seeking a suitable candidate for appointment as Independent Director.
Date of appointment to current position
16/07/2020
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director
Role and responsibilities
Independent Director, Chairman of the Remuneration Committee and Member of the Nominating Committee
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of independent directors currently resident in Singapore (taking into account this cessation)
2
Do independent directors make up at least one-third of the board (taking into account this cessation)?
Yes
Number of cessations of appointments specified in Mainboard Rule 704(7) or Catalist Rule 704(6) over the past 12 months
0
Shareholding interest in the listed issuer and its subsidiaries
No
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Other Directorships
Past (for the last 5 years)
None
Present
None